Sharon Mates - 06 Mar 2025 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Chairman and CEO, Director
Signature
/s/ John P. Condon, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
06 Mar 2025
Net transactions value
-$3,933,189
Form type
4
Filing time
10 Mar 2025, 18:01:06 UTC
Previous filing
04 Mar 2025
Next filing
31 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise +40,712 +3.7% 1,144,646 06 Mar 2025 Direct F1
transaction ITCI Common Stock Tax liability $2,603,859 -19,848 -1.7% $131.19 1,124,798 06 Mar 2025 Direct F2
transaction ITCI Common Stock Options Exercise +20,566 +1.8% 1,145,364 10 Mar 2025 Direct F1
transaction ITCI Common Stock Tax liability $1,329,330 -10,129 -0.88% $131.24 1,135,235 10 Mar 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Options Exercise $0 -40,712 -50% $0.000000 40,713 06 Mar 2025 Common Stock 40,712 Direct F3, F4
transaction ITCI Restricted Stock Units Options Exercise $0 -20,566 -100% $0.000000 0 10 Mar 2025 Common Stock 20,566 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units and does not represent a sale by the reporting person.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 On March 6, 2023, the reporting person was granted 122,137 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
F5 On March 10, 2022, the reporting person was granted 61,696 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.